Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice
Smagulova, K
Abstract GLP-1 receptor agonists used for the treatment of diabetes, have shown some neuroprotective effects in cellular and animal models of Alzheimers disease (AD) and Parkinsons disease (PD)
Although many studies have confirmed that GLP-1RA is related to some tumor diseases and can affect tumor development, these results cannot be used as a guide for clinical treatment because of the lack of clinical trials
A small percentage of patients lose significantly more
At the same time, in our previous study on the protective effect of Ebselen on renal ischemia-reperfusion injury, we found that the expression level of GPX3 in renal tissues decreased after renal IRI, and when the level of GPX3 increased after the use of Ebselen, the pathological damage of renal histologic damage was alleviated, and we speculated that GPX3 may play an important role in the oxidative stress response of renal ischemia-reperfusion injury (Wu et al., 2022)
